Modulators of neuronal cell death in epilepsy

David C Henshall1, Brona M Murphy

  • 1Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland. dhenshall@rcsi.ie

Insights

Certain seizures damage brain, leading to neuronal loss and cognitive impairments. Manipulating specific genes (Bcl-2 family) shows potential for neuroprotection and preventing epilepsy development.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Epilepsy Research

Background:

  • Seizures can cause brain damage and neuronal loss, potentially leading to cognitive deficits and epilepsy.
  • The Bcl-2 gene family and related proteins play critical roles in neuronal survival and apoptosis.

Purpose of the Study:

  • To investigate the role of Bcl-2 family genes and other molecular targets in neuronal death during seizures.
  • To explore the potential of manipulating these targets for neuroprotection and anti-epileptogenic strategies.

Main Methods:

  • Utilized genetically modified mice, Tat protein transduction, and viral vectors to manipulate gene expression.
  • Examined the effects of these manipulations on neuronal death in status epilepticus models.
  • Analyzed hippocampal gene expression and endoplasmic reticulum stress markers in epilepsy patients.

Main Results:

  • Functional effects of manipulating Bcl-2, Bcl-w, heat shock proteins, caspases, and endonucleases on neuronal death were observed.
  • Ancillary effects on seizure induction and excitability thresholds were noted for several genes.
  • Differing hippocampal expression of Bcl-2 family genes, elevated endoplasmic reticulum stress chaperones, and modulated death receptor pathways were found in epilepsy patients.

Conclusions:

  • Targeting Bcl-2 family proteins and related pathways offers potential neuroprotective strategies against seizure-induced brain damage.
  • Modulating these molecular targets may provide adjunctive therapies to prevent epilepsy development or progression.
  • Findings highlight the clinical relevance of studying these molecular mechanisms in human epilepsy.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...